Dr Jess Dyson
Dr Dipanker Chattopadhyay
Rajiv Lochan Jayadeva
Dr Imran Patanwala
Mike Cole
et al. | Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team | 2014 |
|
Dr Joseph Gray
Dr Dipanker Chattopadhyay
Dr Gary Beale
Dr Gillian Patman
Dr Luca Miele
et al. | A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease | 2009 |
|
Dr Gary Beale
Dr Dipanker Chattopadhyay
Dr Joseph Gray
Dr Stephen Stewart
Dr Mark Hudson
et al. | AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease | 2008 |
|
Dr Dipanker Chattopadhyay
Professor Alastair Burt
Professor Chris Day
| Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers | 2008 |
|
Dr Dipanker Chattopadhyay
Professor Helen Reeves
| Oncogenes and tumour suppressor genes | 2007 |
|
Dr Dipanker Chattopadhyay
Professor Derek Manas
Professor Helen Reeves
| The development of targeted therapies for hepatocellular cancer | 2007 |
|
Dr Barry King
Dr Pamela MacDonald
Dr Dipanker Chattopadhyay
Professor Helen Reeves
| The Kruppel-like factor 6 tumour suppressor induces apoptosis in HepG2 cells | 2005 |
|
